Showing results (241-250 of 283) with videos related to

Sort By:
Pageof 29
Cancers|May 16, 2023
Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-FetoproteinTakahiro Kinami, Kei Amioka, Tomokazu Kawaoka, et al.
Journal of Gastroenterology|July 26, 2017
Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver diseaseTakashi Nakahara, Hideyuki Hyogo, Atsushi Ono, et al.
Journal of Gastroenterology|November 9, 2016
ITPA polymorphism effects on decrease of hemoglobin during sofosbuvir and ribavirin combination treatment for chronic hepatitis CKei Morio, Michio Imamura, Yoshiiku Kawakami, et al.
Liver Cancer|May 12, 2021
Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal VeinYumi Kosaka, Tomoki Kimura, Tomokazu Kawaoka, et al.
Plos One|August 11, 2017
The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapyYuko Nagaoki, Michio Imamura, Hiroshi Aikata, et al.
BMC Cancer|November 29, 2022
Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumorsYuki Yoshikawa, Michio Imamura, Masami Yamauchi, et al.
Cancers|February 11, 2023
Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma-Consideration of the Locations of Target LesionsShigeki Yano, Tomoki Kimura, Tomokazu Kawaoka, et al.
Communications Medicine|October 25, 2023
Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinomaMasami Yamauchi, Atsushi Ono, Kei Amioka, et al.
Internal Medicine (Tokyo, Japan)|July 1, 2021
Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with SorafenibKenji Yamaoka, Tomokazu Kawaoka, Hiroshi Aikata, et al.
Plos One|December 31, 2013
HLA-DQB1*03 confers susceptibility to chronic hepatitis C in Japanese: a genome-wide association studyDaiki Miki, Hidenori Ochi, Atsushi Takahashi, et al.
Pageof 29